Abstract:CD14 interacts with a diverse array of pathogen‐associated molecular patterns (PAMPs) and damage‐associated molecular patterns (DAMPs). Subsequently, the CD14‐toll‐like receptors (TLRs)‐ligand complex undergoes internalisation, resulting in reduced CD14 expression on the monocyte surface. The present results provide support that Kawasaki disease (KD) is one of the PAMPs/DAMPs‐associated diseases, and suggest that inflammation and oxidative stress work together complementarily to the development of systemic vasculitis in KD. Real‐time monitoring of CD14 expression on monocytes would be beneficial for managing KD. Objectives The objectives of this study were to investigate the pathophysiology of Kawasaki disease (KD) from immunological and oxidative stress perspectives, and to identify real‐time biomarkers linked to innate immunity and oxidative stress in KD. Methods We prospectively enrolled 85 patients with KD and 135 patients with diverse conditions including immune, infectious and non‐infectious diseases for this investigation. Flow cytometry was used to analyse the surface expression of CD14, CD38 and CD62L on monocytes, along with a quantitative assessment of CD14 down‐modulation. Additionally, oxidative stress levels were evaluated using derivatives of reactive oxygen metabolites (d‐ROMs) and antioxidant capacity measured by a free radical elective evaluator system. Results During the acute phase of KD, we observed a prominent CD14 down‐modulation on monocytes, reflecting the indirect detection of circulating innate immune molecular patterns. Moreover, patients with KD showed a significantly higher CD14 down‐modulation compared with infectious and non‐infectious disease controls. Notably, the surface expression of CD14 on monocytes was restored concurrently with responses to intravenous immunoglobulin and infliximab treatment in KD. Furthermore, d‐ROM levels in patients with KD were significantly elevated compared with patients with infectious and non‐infectious diseases. Following intravenous immunoglobulin treatment, oxidative stress levels decreased in patients with KD. Conclusion Monitoring CD14 down‐modulation on monocytes in real‐time is a valuable strategy for assessing treatment response, distinguishing KD relapse from concomitant infections and selecting second‐line therapy after IVIG treatment in KD patients. The interplay between inflammation and oxidative stress likely plays a crucial role in the development of KD.

CD14 down‐modulation as a real‐time biomarker in Kawasaki disease

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease.

Changes in CD_(69),CD_(25) and HLA-DR Expressions in Peripheral Blood T Cells in Kawasaki Disease

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease

Markedly elevated CD64 expression on neutrophils and monocytes as a biomarker for diagnosis and therapy assessment in Kawasaki disease

The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease

Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease

Monocyte‐Derived Interleukin‐1β As the Driver of S100A12‐Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease

Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients

Platelet-Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease

Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease

Atlas of circulating immune cells in Kawasaki disease

CXCL10/IP-10 Is a Biomarker and Mediator for Kawasaki Disease

Abstract 9361: Interleukin-33 System as Potential Biomarker and Therapeutic Target in Kawasaki Disease

Indicators of Oxidative Stress in the Prediction of Coronary Artery Lesions in Patients With Kawasaki Disease

Expansion of a Novel Subset of L-Selectin+ Classical Monocytes in Kawasaki Disease

The up‐to‐date pathophysiology of Kawasaki disease

Delineation of Single-cell Altas Provides New Insights for Development of Coronary Artery Lesions in Kawasaki Disease: Bad and Good Signaling Molecules

Single-cell mapping of peripheral blood mononuclear cells reveals key transcriptomic changes favoring coronary artery lesion in IVIG-resistant Kawasaki disease

Correlation Analysis of Anti-Cardiolipin Antibody/D Dimer/C-Reactive Protein and Coronary Artery Lesions/Multiple-Organ Damage in Children With Kawasaki Disease